Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Pulmonology

Clinical Pharmacology

ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial–mesenchymal transition

BMC Pulmonary Medicine | May 28, 2021 Clinical Pharmacology

Response to first‐line treatment predicts progression‐free survival benefit of small‐cell lung cancer patients treated with anlotinib

Cancer Medicine | May 28, 2021 Clinical Pharmacology

The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment

Cancer Medicine | May 28, 2021 Clinical Pharmacology

Randomized, controlled trial of sitagliptin and islet function in cystic fibrosis with abnormal glucose tolerance

Journal of Clinical Endocrinology and Metabolism | May 27, 2021 Clinical Pharmacology

Pulmonary tuberculosis and management of contact patients in a department of nephrology and kidney transplantation

International Journal of Infectious Diseases | May 27, 2021 Clinical Pharmacology

Triple vs dual inhaler therapy and asthma outcomes in moderate to severe asthma

JAMA | May 24, 2021 Clinical Pharmacology

Nasal high‐flow oxygen vs conventional oxygen therapy for acute severe asthma patients: A pilot randomized controlled trial

Academic Emergency Medicine | May 24, 2021 Clinical Pharmacology

Is systemic anticancer therapy associated with higher rates of malignant pleural effusion control in people with pharmacologically-sensitive tumours?: A retrospective analysis of prospectively collected data

Chest | May 22, 2021 Clinical Pharmacology

A phase 3, randomized, investigator-blinded trial comparing ceftobiprole with a standard-of-care cephalosporin, with or without vancomycin, for the treatment of pneumonia in pediatric patients

The Pediatric Infectious Disease Journal | May 19, 2021 Clinical Pharmacology

Tezepelumab in adults and adolescents with severe, uncontrolled asthma

New England Journal of Medicine | May 18, 2021 Clinical Pharmacology

« Prev 1 … 7 8 9 10 11 … 80 Next »

ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial–mesenchymal transition

Response to first‐line treatment predicts progression‐free survival benefit of small‐cell lung cancer patients treated with anlotinib

The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment

Randomized, controlled trial of sitagliptin and islet function in cystic fibrosis with abnormal glucose tolerance

Pulmonary tuberculosis and management of contact patients in a department of nephrology and kidney transplantation

Triple vs dual inhaler therapy and asthma outcomes in moderate to severe asthma

Nasal high‐flow oxygen vs conventional oxygen therapy for acute severe asthma patients: A pilot randomized controlled trial

Is systemic anticancer therapy associated with higher rates of malignant pleural effusion control in people with pharmacologically-sensitive tumours?: A retrospective analysis of prospectively collected data

A phase 3, randomized, investigator-blinded trial comparing ceftobiprole with a standard-of-care cephalosporin, with or without vancomycin, for the treatment of pneumonia in pediatric patients

Tezepelumab in adults and adolescents with severe, uncontrolled asthma

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial–mesenchymal transition

Response to first‐line treatment predicts progression‐free survival benefit of small‐cell lung cancer patients treated with anlotinib

The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment

Randomized, controlled trial of sitagliptin and islet function in cystic fibrosis with abnormal glucose tolerance

Pulmonary tuberculosis and management of contact patients in a department of nephrology and kidney transplantation

Triple vs dual inhaler therapy and asthma outcomes in moderate to severe asthma

Nasal high‐flow oxygen vs conventional oxygen therapy for acute severe asthma patients: A pilot randomized controlled trial

Is systemic anticancer therapy associated with higher rates of malignant pleural effusion control in people with pharmacologically-sensitive tumours?: A retrospective analysis of prospectively collected data

A phase 3, randomized, investigator-blinded trial comparing ceftobiprole with a standard-of-care cephalosporin, with or without vancomycin, for the treatment of pneumonia in pediatric patients

Tezepelumab in adults and adolescents with severe, uncontrolled asthma

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Select Specialty

Select Topic